![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » KV Pharmaceutical Signs Second International Licensing Agreement
KV Pharmaceutical Signs Second International Licensing Agreement
KV Pharmaceutical Company has concluded an exclusive licensing agreement with Sigma Pharma Ltda., a division of EMS S/A, to market KV's single-dose prescription cream treatment for bacterial vaginosis (BV) in Brazil. The product is currently marketed in the U.S. by KV's Ther-Rx Corporation subsidiary under the brand name Clindesse (clindamycin phosphate) Vaginal Cream, 2 percent.
Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=e3d560ca4aeebd72&cat=6dcd932030878143)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
18Jul
-
21Oct